XML 80 R69.htm IDEA: XBRL DOCUMENT
v3.26.1

Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Stock Equivalents (Details) - shares | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2026 | Mar. 31, 2025 | Dec. 31, 2025 | Dec. 31, 2024
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 762,457 |  | 775,790 | 1,586,624
Total common stock equivalents included in dilutive income per share |  | 21,801 |  |
HBC Earnout Shares [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 4,000 |  |  | 450,000
Warrants – Public [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 123,500 |  | 123,500 | 123,500
Warrants - Private [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 108,100 |  | 108,100 | 108,100
Warrants - Series A [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 508,857 |  | 508,857 | 167,976
Stock-based compensation - equity awards [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 6,000 |  | 19,333 |
Stock-based compensation - warrants [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents excluded from dilutive loss per share | 12,000 |  | 12,000 |
Stock-based compensation - equity awards [Member] |  |  |  |
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items] |  |  |  |
Total common stock equivalents included in dilutive income per share |  | 21,801 |  |

X
- Definition The amount of antidilutive securities included from computation of earnings per share. + References No definition available. + Details
Name: | sti_AntidilutiveSecuritiesIncludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | sti_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_HBCEarnoutSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_WarrantsPublicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_WarrantsPrivateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_WarrantsSeriesAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_StockbasedCompensationWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sti_StockBasedCompensationEquityAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |